Fluconazole price December 2025 and outlook (see chart below)
- India:US$66.4/KG, -0.2% down
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Fluconazole price index
This post is a summary of the Fluconazole price developments. The price developments of Fluconazole are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Fluconazole price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Fluconazole prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Fluconazole prices
- Recent price developments of underlying feedstocks which drive the price of Fluconazole
- Market futures for both cost drives and feedstocks of Fluconazole prices
- Adjustment of current supply/demand imbalances in the Fluconazole market
- Longer term trends in likely demand conditions
What is Fluconazole and what is it used for
Fluconazole is a triazole antifungal medication (brand name Diflucan) used to treat and prevent a wide range of fungal and yeast infections — from vaginal candidiasis and oral/throat (oropharyngeal) candidiasis to systemic Candida infections and cryptococcal meningitis in susceptible patients. It is commonly given orally or intravenously depending on the infection and patient status.
How is Fluconazole produced
Fluconazole is made by multi-step organic synthesis from simple aromatic precursors. Published methods (including Pfizer’s original approaches) use sequences such as acylation, construction of the triazole ring and subsequent functional-group transformations; many later patents and academic reviews describe simplified or improved multi-step routes and process optimisations used at scale. Production requires standard pharmaceutical API process controls (purification, crystallization, GMP).
How large is the global market for Fluconazole
Market research reports estimate the global fluconazole market in the low single-digit billions of US dollars (examples: several market reports place 2024 valuations around USD ~2.5 billion with forecasts showing mid-single-digit CAGR growth through the 2020s). Reported figures vary by provider and methodology, so headline numbers should be taken as market-report estimates rather than official sales statistics.
Where is Fluconazole produced
Fluconazole is produced both by originator pharmaceutical manufacturers (Pfizer historically commercialised Diflucan) and by many generic drug companies. Active pharmaceutical ingredient (API) and finished-dose manufacturing is concentrated among large generic and API producers in India and China, with additional manufacturing by multinational firms in Europe, North America and other regions. Major manufacturers and suppliers listed in market and industry databases include Pfizer (originator), Teva/Viatris, Sandoz/Novartis, Aurobindo, Sun Pharma, Cipla, Dr. Reddy’s and numerous Indian and Chinese API exporters.